BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $55.00
BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target raised by Scotiabank from $52.00 to $55.00 in a research report sent to investors on Wednesday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock. Several other research analysts have also recently commented on the company. HC Wainwright boosted their target price on […]
BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target raised by Scotiabank from $52.00 to $55.00 in a research report sent to investors on Wednesday,Benzinga reports. Scotiabank currently has a sector outperform rating on the stock. Several other research analysts have also recently commented on the company. HC Wainwright boosted their target price on […]
